1. Home
  2. MOVE vs SDGR Comparison

MOVE vs SDGR Comparison

Compare MOVE & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MOVE

Movano Inc.

HOLD

Current Price

$19.61

Market Cap

901.4M

Sector

Health Care

ML Signal

HOLD

Logo Schrodinger Inc.

SDGR

Schrodinger Inc.

HOLD

Current Price

$12.76

Market Cap

925.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOVE
SDGR
Founded
2018
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
901.4M
925.8M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
MOVE
SDGR
Price
$19.61
$12.76
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$21.00
AVG Volume (30 Days)
46.9K
1.5M
Earning Date
04-08-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
45.14
EPS
N/A
N/A
Revenue
$433,000.00
$255,869,000.00
Revenue This Year
$1,460.71
$0.76
Revenue Next Year
$96.77
$4.60
P/E Ratio
N/A
N/A
Revenue Growth
N/A
23.29
52 Week Low
$0.51
$10.95
52 Week High
$34.87
$27.63

Technical Indicators

Market Signals
Indicator
MOVE
SDGR
Relative Strength Index (RSI) 64.68 55.06
Support Level $6.27 $11.18
Resistance Level $19.45 $13.33
Average True Range (ATR) 1.72 0.65
MACD 0.08 0.05
Stochastic Oscillator 99.85 69.43

Price Performance

Historical Comparison
MOVE
SDGR

About MOVE Movano Inc.

Corvex Inc is an AI cloud computing company specializing in GPU accelerated infrastructure for AI workloads. The company provides AI-focused computing infrastructure that offers scalable computational resources. Its platform uses GPU-accelerated compute clusters and high-throughput storage to support performance, security, and efficiency at scale. The company's product portfolio includes GPU Clusters, Inference-as-a-Service, Confidential Computing, and GPU Node.

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.

Share on Social Networks: